Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Directing the ratio of B2:B1 avermectins in Streptomyces avermitilis host cells

Directing the ratio of B2:B1 avermectins in Streptomyces avermitilis host cells

US Patent 6632673 · Granted Oct 14, 2003

Estimated economic value: $299,772,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chimeric antigen receptors specific for B-cell maturation antigen and encoding p2025
Modification of CAR-T cells2025
Ketoreductase polypeptides for the reduction of acetophenones2025
Transposition of nucleic acids into eukaryotic genomes with a transposase from h2025
Modifications of mammalian cells using artificial micro-RNA to alter their prope2025
Tetracycline-inducible expression system2025
Semiconductor device and manufacturing method thereof2025
Antibodies to Feline McDonough Sarcoma (FMS)-like tyrosine kinase 3 receptor lig2025
DNA vectors, transposons and transposases for eukaryotic genome modification2024
Anti-IL-6 antibody2024
DNA vectors, transposons and transposases for eukaryotic genome modification2024
Antibodies and chimeric antigen receptors specific for ROR12024